Malathi Shivaprakash

Statistics

Publications

Citations

1.3K

H-Index

Active since

1995

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Malathi Shivaprakash is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in infectious diseases, pharmacotherapy, and pharmacology.

Publications per year

1995–2010

Publications

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

Jon H. Condra, William A. Schleif, O M Blahy et al. · Nature · 1995 · 979 citations

Life Sciences, Infectious Diseases, Molecular Biology +16

Drug Resistance and Predicted Virologic Responses to Human Immunodeficiency Virus Type 1 Protease Inhibitor Therapy

Jon H. Condra, Christos J. Petropoulos, Rainer Ziermann et al. · The Journal of Infectious Diseases · 2000 · 139 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Crossover Comparison of Efficacy and Preference for Rizatriptan 10 mg versus Ergotamine/Caffeine in Migraine

Suzanne Christie, Hartmut Göbel, V Mateos et al. · European Neurology · 2002 · 78 citations

Medicine, Pharmacology, Pharmacotherapy +15

Caspofungin Use in Daily Clinical Practice for Treatment of Invasive Aspergillosis: Results of a Prospective Observational Registry

Johan Maertens, Gerlinde Egerer, Wan Shik Shin et al. · BMC Infectious Diseases · 2010 · 46 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

Efficacy and Safety of Ertapenem Versus Piperacillin-Tazobactam for the Treatment of Intra-Abdominal Infections Requiring Surgical Intervention

Arturo Peña, Walter Asperger, Ferdinand Köckerling et al. · Journal of Gastrointestinal Surgery · 2006 · 42 citations

Medicine, Pharmacology, Surgery +12

1–5 of 8